Retour
Fourchette du Jour
30,11 €
31,44 €
Fourchette 52 Semaines
30,11 €
90,32 €
Volume
2 160 431
Moyenne 50J / 200J
39,76 €
/
59,33 €
Clôture Précédente
31,72 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 80,6 | 0,4 |
| P/B | 3,7 | 2,9 |
| ROE % | 6,0 | 3,7 |
| Net Margin % | 11,0 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
101,20 €
+222.9%
Low: 60,00 €
High: 125,00 €
P/E Prévisionnel
8,2
BPA Prévisionnel
3,89 €
Croissance BPA (est.)
+0,0%
CA Est.
470 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
16,04 €
14,31 € – 18,79 €
|
1,6 B | 5 |
| FY2029 |
12,81 €
11,43 € – 15,01 €
|
1,4 B | 2 |
| FY2028 |
9,18 €
4,72 € – 13,23 €
|
1 B | 7 |
Points Clés
Debt/Equity of 0,01 — conservative balance sheet
Generating 46,73M in free cash flow
P/E of 80,58 — premium valuation
Cash machine — converts 223,67% of earnings into free cash flow
Capital efficient — spends only 0,04% of revenue on capex
ROIC of 2,48% — low return on invested capital
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
6,01%
ROIC2,48%
Net Margin10,97%
Op. Margin7,85%
Sécurité
Debt / Equity
0,01
Current Ratio5,80
Interest Coverage2,73
Valorisation
P/E Ratio
80,58
P/B Ratio3,74
EV/EBITDA108,08
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 190,41M | Net Income (TTM) | 20,89M |
| ROE | 6,01% | ROA | 3,71% |
| Gross Margin | 98,58% | Operating Margin | 7,85% |
| Net Margin | 10,97% | Free Cash Flow (TTM) | 46,73M |
| ROIC | 2,48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,80 |
| Interest Coverage | 2,73 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 80,58 | P/B Ratio | 3,74 |
| P/S Ratio | 8,84 | PEG Ratio | -1,08 |
| EV/EBITDA | 108,08 | Dividend Yield | 0,00% |
| Market Cap | 1,68B | Enterprise Value | 1,62B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 190,41M | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | 20,89M | -175,85M | -38,99M | -24,07M | -30,91M |
| EPS (Diluted) | 0,39 | -4,38 | -2,36 | -2,87 | -5,81 |
| Gross Profit | 187,71M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | 14,95M | -187,67M | -41,38M | -24,40M | -31,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 563,83M | 330,97M | 180,69M | 26,50M | 35,55M |
| Total Liabilities | 113,72M | 85,86M | 23,18M | 16,15M | 17,76M |
| Shareholders' Equity | 450,12M | 245,11M | 157,51M | 10,35M | 17,79M |
| Total Debt | 2,69M | 52,83M | 403 000,0 | 155 000,0 | 457 000,0 |
| Cash & Equivalents | 70,11M | 87,93M | 169,68M | 14,60M | 21,30M |
| Current Assets | 355,81M | 293,89M | 171,36M | 15,65M | 22,42M |
| Current Liabilities | 61,36M | 18,75M | 11,51M | 7,31M | 8,01M |